PharmGen Science, Inc. (KRX: 004720)
South Korea
· Delayed Price · Currency is KRW 4,650.00
+105.00 (2.31%)
Nov 15, 2024, 3:30 PM KST
PharmGen Science Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 173,095 | 166,779 | 150,931 | 109,866 | 96,614 | 95,138 | Upgrade
|
| Other Revenue | 0 | - | - | -0 | - | - | Upgrade
|
| Revenue | 173,095 | 166,779 | 150,931 | 109,866 | 96,614 | 95,138 | Upgrade
|
| Revenue Growth (YoY) | 12.18% | 10.50% | 37.38% | 13.72% | 1.55% | 6.77% | Upgrade
|
| Cost of Revenue | 68,874 | 69,029 | 69,857 | 49,136 | 43,085 | 44,852 | Upgrade
|
| Gross Profit | 104,221 | 97,749 | 81,073 | 60,730 | 53,529 | 50,286 | Upgrade
|
| Selling, General & Admin | 86,454 | 81,752 | 69,089 | 61,822 | 50,270 | 45,473 | Upgrade
|
| Research & Development | 4,946 | 5,118 | 2,886 | 2,270 | 1,115 | 886.3 | Upgrade
|
| Other Operating Expenses | 187.98 | 206.93 | 203.02 | 175.86 | 109.92 | 111.25 | Upgrade
|
| Operating Expenses | 93,735 | 88,623 | 73,662 | 65,668 | 55,434 | 49,089 | Upgrade
|
| Operating Income | 10,486 | 9,127 | 7,412 | -4,938 | -1,905 | 1,197 | Upgrade
|
| Interest Expense | -4,264 | -4,264 | -3,509 | -1,721 | -289.55 | -1,475 | Upgrade
|
| Interest & Investment Income | 98.41 | 98.41 | 66.04 | 87.8 | 119.67 | 443.43 | Upgrade
|
| Earnings From Equity Investments | -5,011 | -2,996 | 87,213 | 46,633 | 14,508 | 103.21 | Upgrade
|
| Currency Exchange Gain (Loss) | 217.94 | 217.94 | 13.97 | 0.2 | -24.05 | 2.22 | Upgrade
|
| Other Non Operating Income (Expenses) | 370.53 | 5,938 | -1,115 | 2,699 | -31.05 | 73.67 | Upgrade
|
| EBT Excluding Unusual Items | 1,897 | 8,122 | 90,081 | 42,760 | 12,378 | 344.56 | Upgrade
|
| Gain (Loss) on Sale of Investments | 51.6 | 51.6 | 9.77 | 1.11 | -1,085 | 43.58 | Upgrade
|
| Gain (Loss) on Sale of Assets | 46.35 | 46.35 | 2.94 | -11.49 | -29.13 | 16.05 | Upgrade
|
| Asset Writedown | -228.3 | -228.3 | -133.08 | -799.9 | -53.75 | - | Upgrade
|
| Pretax Income | 1,767 | 7,991 | 89,960 | 41,949 | 11,209 | 404.18 | Upgrade
|
| Income Tax Expense | 1,212 | 2,265 | 19,902 | 9,535 | 2,085 | 168.18 | Upgrade
|
| Earnings From Continuing Operations | 554.5 | 5,726 | 70,058 | 32,414 | 9,124 | 236 | Upgrade
|
| Minority Interest in Earnings | 1.25 | 1.04 | 1.48 | 51.54 | 98.12 | 65.98 | Upgrade
|
| Net Income | 555.75 | 5,727 | 70,060 | 32,466 | 9,222 | 301.98 | Upgrade
|
| Net Income to Common | 555.75 | 5,727 | 70,060 | 32,466 | 9,222 | 301.98 | Upgrade
|
| Net Income Growth | -92.83% | -91.83% | 115.79% | 252.04% | 2953.92% | -93.24% | Upgrade
|
| Shares Outstanding (Basic) | 17 | 16 | 16 | 15 | 14 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 21 | 21 | 22 | 19 | 15 | 12 | Upgrade
|
| Shares Change (YoY) | -23.67% | -3.68% | 16.09% | 23.81% | 30.15% | -3.86% | Upgrade
|
| EPS (Basic) | 31.84 | 351.99 | 4498.10 | 2206.02 | 674.98 | 26.16 | Upgrade
|
| EPS (Diluted) | 31.84 | 306.26 | 3369.29 | 1814.33 | 623.34 | 26.00 | Upgrade
|
| EPS Growth | -91.53% | -90.91% | 85.70% | 191.07% | 2297.46% | -93.11% | Upgrade
|
| Free Cash Flow | 1,841 | 3,173 | -11,208 | -22,966 | -1,664 | -3,637 | Upgrade
|
| Free Cash Flow Per Share | 86.93 | 152.58 | -519.12 | -1234.84 | -110.74 | -315.08 | Upgrade
|
| Gross Margin | 60.21% | 58.61% | 53.72% | 55.28% | 55.40% | 52.86% | Upgrade
|
| Operating Margin | 6.06% | 5.47% | 4.91% | -4.49% | -1.97% | 1.26% | Upgrade
|
| Profit Margin | 0.32% | 3.43% | 46.42% | 29.55% | 9.55% | 0.32% | Upgrade
|
| Free Cash Flow Margin | 1.06% | 1.90% | -7.43% | -20.90% | -1.72% | -3.82% | Upgrade
|
| EBITDA | 15,082 | 13,374 | 10,783 | -1,796 | 1,057 | 3,519 | Upgrade
|
| EBITDA Margin | 8.71% | 8.02% | 7.14% | -1.63% | 1.09% | 3.70% | Upgrade
|
| D&A For EBITDA | 4,597 | 4,247 | 3,371 | 3,142 | 2,963 | 2,322 | Upgrade
|
| EBIT | 10,486 | 9,127 | 7,412 | -4,938 | -1,905 | 1,197 | Upgrade
|
| EBIT Margin | 6.06% | 5.47% | 4.91% | -4.49% | -1.97% | 1.26% | Upgrade
|
| Effective Tax Rate | 68.62% | 28.34% | 22.12% | 22.73% | 18.60% | 41.61% | Upgrade
|
| Advertising Expenses | - | 2,345 | 2,833 | 2,168 | 1,853 | 2,332 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.